ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 2,140.00

From 52W high−28.55%

Volume70800.00

Market capJPY 60.77B

P/E (TTM)12.9x

P/S (TTM)0.9x

Div yield2.57%

Key dataSep 18, 2026

Open

JPY 2,140.00

From 52W high

−28.55%

Volume

70800.00

Market cap

JPY 60.77B

ValuationView details →

P/E (Fwd)

16.1x

EV/EBITDA

10.5x

P/E (TTM)

12.9x

RSI (14)

58.4

MomentumView details →

1D Return

+0.56%

YTD Return

+6.43%

ValuationView details →

P/E (Fwd)

16.1x

P/E (TTM)

12.9x

EV/EBITDA

10.5x

EV/Sales

1.0x

P/S (TTM)

0.9x

P/B (TTM)

0.9x

ProfitabilityView details →

Gross Margin

48.01%

Net Margin

7.63%

EBITDA Margin

12.30%

ROE (TTM)

7.09%

ROA (TTM)

4.84%

Asset Turnover

0.63x

GrowthView details →

Revenue YoY

+10.90%

EPS YoY

+6.19%

FCF YoY

—

Revenue CAGR 3Y

+5.56%

EPS CAGR 3Y

+8.39%

EBITDA YoY

—

MomentumView details →

1D Return

+0.56%

YTD Return

+6.43%

1Y Return

−9.09%

RSI (14)

58.4

vs 50D SMA

+1.14%

vs 200D SMA

−7.26%

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

2.76x

Quick Ratio

2.09x

Div Yield

2.57%

Div Rate

JPY 60.00

Div Growth 1Y

+9.09%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

71.13B

Net Income (TTM)

5.42B

Op. CF (TTM)

—

Next earningsNov 9, 2026 →

Latest newsMore news →

No recent news for 4886.T.

Similar companies

JCR Pharmaceuticals Co.,Ltd.4552.T KYORIN Pharmaceutical Co.,Ltd.4569.T SanBio Company Limited4592.T Heartseed Inc.219A.T TAUNS Laboratories,Inc.197A.T Cuorips Inc.4894.T Find similar companies →

Latest newsMore news →

No recent news for 4886.T.